Stock HPHA HEIDELBERG PHARMA AG
Add to a list
To use this feature you must be a member
Log inSign up

All News Heidelberg Pharma AG

Equities

HPHA

DE000A11QVV0

Market Closed - Xetra
Other stock markets
 11:36:13 2024-05-22 am EDT 		After market 01:00:36 pm
2.97 EUR 0.00% Intraday chart for Heidelberg Pharma AG 2.945 -0.84%
Apr. 25 Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
Apr. 23 Transcript : Heidelberg Pharma AG - Special Call

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Heidelberg Pharma : Agenda and convening of the general meeting (published in Bundesanzeiger on 13 May 2024)
PU
Heidelberg Pharma : Report of the Management Board on agenda item 5
PU
Heidelberg Pharma : Aktuelle Unternehmenspräsentation, Mai 2024
PU
Heidelberg Pharma : Current Company Presentation, May 2024
PU
Heidelberg Pharma : Remuneration Report 2023
PU
Heidelberg Pharma : Remuneration report for the financial year 2022/2023 including audit opinion
PU
Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
EQ
Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024
CI
Transcript : Heidelberg Pharma AG - Special Call
DD: Heidelberg Pharma AG: Walter Miller, buy
EQ
Heidelberg Pharma to host R&D Webinar following novel data presented at AACR
EQ
PM: Heidelberg Pharma receives Orphan Drug Designation from the FDA for its ATAC candidate HDP-101
AQ
Heidelberg Pharma Wins US FDA Orphan Drug Designation for Multiple Myeloma Treatment
MT
Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
EQ
DD: Heidelberg Pharma AG: Dr. Georg F. Baur, buy
EQ
Heidelberg Pharma : Presentation Analyst and Press Conference 2024
PU
Heidelberg Pharma : Präsentation Bilanzpressekonferenz 2024
PU
Transcript : Heidelberg Pharma AG, 2023 Earnings Call, Mar 25, 2024
Heidelberg Pharma announces financial figures and reports on successful business performance in 2023
EQ
Heidelberg Pharma AG Reports Earnings Results for the Full Year Ended November 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HPHA Stock
  4. News Heidelberg Pharma AG
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW